Syneos Health Stockholders Approve Agreement with Private Investment Consortium
02. August 2023 08:47 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today...
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer
10. Juli 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., July 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Hillary...
Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
26. Juni 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
25. Mai 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha...
Syneos Health Leaders Recognized by HBA
17. Mai 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 17, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced that Jennifer Sozio, SVP...
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
16. Mai 2023 08:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu,...
Syneos Health Reports First Quarter 2023 Results
10. Mai 2023 07:07 ET
|
Syneos Health, Inc.
Revenue for the first quarter of $1,356.8 million increased 1.5% on a reported basis and increased 2.4% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion
10. Mai 2023 06:47 ET
|
Syneos Health, Inc.
Shareholders to Receive $43.00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos...
Syneos Health Appoints Michael Bonello as Chief Financial Officer
02. Mai 2023 06:19 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael...
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
13. April 2023 16:31 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial...